Tarsus Pharmaceuticals Inc (TARS) — Cash Flow Quality Index

Latest as of June 2021: 3.24x

Tarsus Pharmaceuticals Inc (TARS) has a Cash Flow Quality Index of 3.24x as of June 2021. Operating cash flow of $20.55 Million exceeds net income of $6.34 Million, indicating high earnings quality where cash backs reported profits. Explore Tarsus Pharmaceuticals Inc (TARS) investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

3.24x

Operating CF / Net Income

Operating Cash Flow

$20.55 Million

USD

Net Income

$6.34 Million

USD

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for Tarsus Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Tarsus Pharmaceuticals Inc. For live market cap and the full company financial profile, see TARS company net worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.